Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06115252 · ClinicalTrials.gov registry record · NA
Partnering to Enhance Emerging Adults' Response to Programs
A NA study of Alcohol Use, Unspecified, sponsored by UConn Health.
- Recruiting
- Registry status
- NA
- Development phase
- 248
- Enrollment target
- 1
- Study location
NCT06115252: Recruiting NA study of Alcohol Use, Unspecified, sponsored by UConn Health.
NCT06115252 is a NA study of Alcohol Use, Unspecified that is actively recruiting participants, run by UConn Health. The registered enrollment target is 248 participants, roughly in line with the 247-participant average among 13 other Alcohol Use, Unspecified trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06115252, a NA study of Alcohol Use, Unspecified, is actively recruiting participants, sponsored by UConn Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 248 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial (CT) is to learn more about emerging adults' and their peers. Here, we will see how co-participating with a peer in health program might impact brain and behavior change over time. Eligible youth will be invited to come in for a "Participation Day," during which they and a peer will independently complete questionnaires. With a peer, they will then complete a short health program, and undergo a brain scan (fMRI) while completing activities. Our study team will reach out to each participant individually again 3, 6, and 12 months later to learn about health behaviors over time.
Primary Outcome
Mean BOLD time series will be obtained for each region of interest (ROI) during peer-directed change talk trials and temporally aligned across dyad participants. Inter-brain synchrony will be quantified using z-transformed GLM β-weights within ROIs between the BOLD time series of dyad members.
Conditions Studied
Interventions
- BEHAVIORAL Motivational Interviewing (MI)
Study Locations (1)
Texas
- University of Texas Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2025-10-10 |
| Est. Completion | 2028-03-31 |
| Phase | NA |
What NCT06115252 shows while recruiting
NCT06115252 is an interventional study that assigns participants to a tested intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 247-participant average among 13 other Alcohol Use, Unspecified trials with a reported enrollment target.
The record links to 1 condition, with Alcohol Use, Unspecified appearing as the primary indexed condition, and to 1 intervention - of which Motivational Interviewing (MI) is the first listed.
NCT06115252 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06115252 about?
NCT06115252 is a clinical study titled "Partnering to Enhance Emerging Adults' Response to Programs". The goal of this clinical trial (CT) is to learn more about emerging adults' and their peers. Here, we will see how co-participating with a peer in health program might impact brain and behavior change over time. Eligible youth will be invited to come in for a "Participation Day," during which they...
What is the current status of trial NCT06115252?
This trial is currently recruiting. It is a NA study. The enrollment target is 248 participants. The study started on 2025-10-10. Estimated completion is 2028-03-31.
What conditions does trial NCT06115252 study?
This clinical trial studies the following conditions: Alcohol Use, Unspecified.
What interventions are being tested in trial NCT06115252?
The interventions under investigation include: Motivational Interviewing (MI) (BEHAVIORAL).
Who is sponsoring clinical trial NCT06115252?
This trial is sponsored by UConn Health, which has 178 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06115252 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Use, Unspecified
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06115252's enrollment target sits among peer trials
248 5th of 13 higher than 9 of 13 other Alcohol Use, Unspecified trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Use, Unspecified trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Distinguishing Alcohol Intoxication, Cannabis Intoxication and Co-intoxication Using Electroencephalography (EEG)
RECRUITING · NA
-
Optimizing a Digital AEP Risk Intervention With Native Women and Communities
RECRUITING · NA
-
Practice Facilitation as a Strategy to Improve Alcohol Treatment Adoption and Implementation in HIV Care
RECRUITING · NA
-
Drinking, Acetate, and Stress
RECRUITING · NA
-
CARS: Cannabis and Alcohol Reduction Study
RECRUITING · NA
-
WayToServePlus: Improving Responsible Alcohol Service Ph II
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI